Physician profile
Louise Lu
NPI 1285261289
$2,251.11
in general payments reported to CMS, 2019-2025
14 companies · $610 in 2025
The $610 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,641 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,210 · Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,210.48 |
| Food and Beverage | $1,040.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,503.61 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $216.69 | 2024-2025 | Clareon, Tryptyr, Hydrus Microstent |
| Tarsus Pharmaceuticals, INC. | $130.59 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $103.27 | 2024-2025 | Miebo, Xiidra, Envista Envy Iol |
| Harrow Eye, LLC | $84.77 | 2025 | Vevye |
| Abbvie INC. | $30.25 | 2025 | |
| Sun Pharmaceutical Industries INC. | $26.64 | 2025 | |
| New World Medical,INC. | $26.02 | 2025 | Clearpath, Ahmed Glaucoma Valve, Via360 |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $23.90 | 2024 | |
| Dompe US, INC. | $22.34 | 2025 | Oxervate |
| Thea Pharma INC. | $22.14 | 2025 | Iyuzeh |
| Sight Sciences, INC. | $22.00 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Biotissue Holdings INC. | $21.71 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $17.18 | 2025 | Tecnis Iol, Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louise Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.